The Inflation Reduction Act of 2022 has enhanced the scope of immunization coverage under Medicare Part D. Both political parties supported the IRA, which tackled the burdensome expense of prescription medicines for the elderly. Up to this juncture, the Medicare provision for vaccinations had been perplexing and intricate.
Previously, vaccines such as for the flu, pneumococcal pneumonia, and COVID-19 incurred no fees during medical office visits. Hepatitis B vaccinations were also offered at no cost for individuals deemed to be at elevated risk. This meant that Medicare originally paid 80 percent of expenses for tetanus and rabies immunizations that were necessary due to puncture injuries and animal scratches.
The scope of coverage for other vaccinations within Medicare Part D plans was inconsistent. For instance, the immunization for shingles (Shingrix), which is advised for all adults aged 50 and above, could impose an out-of-pocket cost exceeding $400 under a Part D policy.
By 2023, an estimated 50 million beneficiaries of Medicare Part D will gain access to their shingles immunization at no charge.
